Yemaachi Biotechnology

About:

Yemaachi Biotechnology provides diversifying precision cancer diagnostics and treatments.

Top Investors: Y Combinator, Tencent, LoftyInc Capital, Bill & Melinda Gates Foundation, True Capital Management

Description:

Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

Total Funding Amount:

$4.43M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Accra, Greater Accra, Ghana

Founded Date:

2020-01-01

Contact Email:

info(AT)yemaachi.com

Founders:

David Hutchful, Joyce Ngoi, Yaw Attua-Afari, Yaw Bediako

Number of Employees:

11-50

Last Funding Date:

2022-03-21

IPO Status:

Private

Industries: